A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system.

Eitemau Tebyg

• The Humoral Immune Response to Human T-Cell Lymphotropic Virus Type 1 Envelope Glycoprotein gp46 Is Directed Primarily against Conformational Epitopes
  gan: Hadlock, Kenneth G., et al.
  Cyhoeddwyd: (1999)
• Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46.
  gan: Hadlock, K G, et al.
  Cyhoeddwyd: (1997)
• Effect of glycosylation inhibitors on the release of enveloped vaccinia virus.
  gan: Payne, L G, et al.
  Cyhoeddwyd: (1982)
• Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.
  gan: Palker, T J, et al.
  Cyhoeddwyd: (1992)
• Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection.
  gan: McMahon-Pratt, D, et al.
  Cyhoeddwyd: (1993)